Literature DB >> 681455

Localization of the guinea pig eosinophil major basic protein to the core of the granule.

D M Lewis, J C Lewis, D A Loegering, G J Gleich.   

Abstract

The localization of the guinea pig eosinophil major basic protein (MBP) within the cell was investigated by the use of immunoelectron microscopy and by isolation of the granule crystalloids. First, by immunoperoxidase electron microscopy, we found that the MBP of eosinophil granules is contained within the crystalloid core of the granule. Specific staining of cores was present when rabbit antiserum to MBP was used as the first stage antibody in a double antibody staining procedure, whereas staining was not seen when normal rabbit serum was used as the first stage antibody. Second, crystalloids were isolated from eosinophil granules by disruption in 0.1% Triton X-100 and centrifugation through a cushion of 50% sucrose. Highly purified core preparations yielded essentially a single band when analyzed by electrophoresis on polyacrylamide gels containing 1% sodium dodecyl sulfate (SDS). The E1%1cm of the core protein was 26.8 +/- 1.0 (X +/- SEM); the E1%1cm for the MBP was 26.3. The core protein could not be distinguished from the MBP by radioimmunoassay (RIA) and essentially all of the protein in the core preparations could be accounted for as MBP. The results indicate that the MBP is contained in the core of the guinea pig eosinophil granule and that it is probably the only protein present in the core.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 681455      PMCID: PMC2110139          DOI: 10.1083/jcb.77.3.702

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  25 in total

1.  The genesis of the Charcot-Leyden crystal in the eosinophilic leukocyte of man.

Authors:  R A WELSH
Journal:  Am J Pathol       Date:  1959 Nov-Dec       Impact factor: 4.307

2.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

3.  Melanin: a normal component of human eosinophils.

Authors:  M R Okun; B Donnellan; S H Pearson; L E Edelstein
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Cytochemical and ultrastructural identification of a small type granule in human late eosinophils.

Authors:  R T Parmley; S S Spicer
Journal:  Lab Invest       Date:  1974-05       Impact factor: 5.662

6.  Comparison of the protein-binding capacities of cyanogen bromide-activated polysaccharides.

Authors:  J W Yunginger; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1972-08       Impact factor: 10.793

7.  Antiserum to the major basic protein of guinea pig eosinophil granules.

Authors:  D M Lewis; D A Loegering; G J Gleich
Journal:  Immunochemistry       Date:  1976-09

8.  Isolation and partial characterization of a major basic protein from rat eosinophil granules.

Authors:  D M Lewis; D A Loegering; G J Gleich
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

9.  The entry of granule-associated peroxidase into the phagocytic vacuoles of eosinophils.

Authors:  R S Cotran; M Litt
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  ISOLATION OF GRANULES FROM EOSINOPHIL LEUCOCYTES AND STUDY OF THEIR ENZYME CONTENT.

Authors:  G T ARCHER; J G HIRSCH
Journal:  J Exp Med       Date:  1963-08-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins.

Authors:  Rossana C N Melo; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

2.  Molecular Biology of Eosinophils: Introduction.

Authors:  Paige Lacy; Helene F Rosenberg; Garry M Walsh
Journal:  Methods Mol Biol       Date:  2021

3.  Selective inflammatory response induced by intratracheal and intravenous administration of poly-L-arginine in guinea pig lungs.

Authors:  D Arseneault; K Maghni; P Sirois
Journal:  Inflammation       Date:  1999-06       Impact factor: 4.092

4.  Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue.

Authors:  G M Kephart; Z A Andrade; G J Gleich
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

5.  Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor.

Authors:  T L Wasmoen; C B Coulam; K M Leiferman; G J Gleich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 6.  A new dawn for eosinophils in the tumour microenvironment.

Authors:  Sharon Grisaru-Tal; Michal Itan; Amy D Klion; Ariel Munitz
Journal:  Nat Rev Cancer       Date:  2020-07-16       Impact factor: 60.716

7.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Authors:  S R White; M E Strek; G V Kulp; S M Spaethe; R A Burch; S P Neeley; A R Leff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Subcellular fractionation of human eosinophils: isolation of functional specific granules on isoosmotic density gradients.

Authors:  Josiane S Neves; Sandra A C Perez; Lisa A Spencer; Rossana C N Melo; Peter F Weller
Journal:  J Immunol Methods       Date:  2009-03-26       Impact factor: 2.303

9.  Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity.

Authors:  R I Abu-Ghazaleh; G J Gleich; F G Prendergast
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

10.  Human eosinophil major basic protein, a mediator of allergic inflammation, is expressed by alternative splicing from two promoters.

Authors:  M S Li; L Sun; T Satoh; L M Fisher; C J Spry
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.